Itraconazole 1% w/w Dusting Powder.
REALZOLE contains Itraconazole 1% w/w Dusting Powder, a topical antifungal formulation used for the treatment and prevention of various fungal skin infections. It helps manage common fungal conditions such as athlete’s foot, ringworm, jock itch, fungal infections in skin folds, and other superficial fungal infections caused by susceptible fungi. The dusting powder also helps keep the affected area dry, reducing excessive moisture that promotes fungal growth.
Itraconazole is a broad-spectrum antifungal agent that works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane. This action weakens the fungal cell structure, stops fungal growth, and helps eliminate the infection. The dusting powder formulation provides effective antifungal protection while offering a soothing, non-greasy application that keeps the skin fresh and comfortable.
Bioglint Derma Care offers a rewarding Itraconazole 1% w/w Dusting Powder PCD Pharma Franchise opportunity for pharma distributors, wholesalers, and healthcare entrepreneurs looking to strengthen their presence in the dermatology segment. As a trusted Itraconazole 1% w/w Dusting Powder manufacturer and supplier, Bioglint Derma Care delivers premium-quality dermatology products manufactured under strict quality standards. The company provides comprehensive franchise support, including promotional materials, attractive packaging, competitive pricing, consistent product availability, and reliable business assistance, enabling partners to establish and grow a successful pharmaceutical business.
REALZOLE (Itraconazole 1% w/w Dusting Powder) is generally well tolerated when used as directed. Some individuals may experience mild skin irritation, redness, itching, burning sensation, dryness, or rash at the application site. These effects are usually temporary and subside as the skin adjusts to the treatment.
The powder should be used only for external application and should be applied to clean, dry skin. Avoid contact with the eyes, mouth, and other mucous membranes. Patients should use the product exactly as advised by their healthcare professional and complete the recommended treatment duration even if symptoms improve earlier. If irritation persists or the infection worsens, discontinue use and consult a healthcare provider.